6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation

被引：0
|
作者：
Wesam M. El-Bakly
Manal L. Louka
Ali M. El-Halawany
Mona F. Schaalan
机构：
[1] Ain Shams University,Department of Pharmacology and Therapeutics, Faculty of Medicine
[2] Ain Shams University,Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine
[3] Cairo University,Department of Pharmacognosy, Faculty of Pharmacy, Kasr El Ainy
[4] Misr International University,Department of Biochemistry, Faculty of Pharmacy
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 70卷
关键词：
Doxorubicin (DOX)-cardiotoxicity; 6-gingerol; Nuclear factor kappa B (NF-κB); Caspase-3; sRAGE (receptor for advanced glycation endproducts);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：833 / 841
页数：8
相关论文
共 50 条
  • [1] 6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation
    El-Bakly, Wesam M.
    Louka, Manal L.
    El-Halawany, Ali M.
    Schaalan, Mona F.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (06) : 833 - 841
  • [2] The role of reactive oxygen species and nuclear factor kappa B in doxorubicin-induced apoptosis
    Wang, SW
    Konorev, E
    Kalivendi, S
    Kotamraju, S
    Kalyanaraman, B
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 : S107 - S107
  • [3] Receptor activator of nuclear factor κB ligand plays a nonredundant role in doxorubicin-induced apoptosis
    Müller, I
    Pfister, SM
    Grohs, U
    Zweigner, J
    Handgretinger, R
    Niethammer, D
    Bruchelt, G
    [J]. CANCER RESEARCH, 2003, 63 (08) : 1772 - 1775
  • [4] Nuclear factor PPAR-α induction in the heart plays a pivotal role in determining the final outcome of doxorubicin-induced cardiotoxicity
    Mitra, Mayurranjan S.
    Donthamsetty, Shishikiran
    Latendresse, John R.
    Mehendale, Harihara M.
    [J]. FASEB JOURNAL, 2007, 21 (06): : A799 - A799
  • [5] The Role of 6-Gingerol on Inhibiting Amyloid β Protein-Induced Apoptosis in PC12 Cells
    Zeng, Gao-feng
    Zong, Shao-hui
    Zhang, Zhi-yong
    Fu, Song-wen
    Li, Ke-ke
    Fang, Ye
    Lu, Li
    Xiao, De-qiang
    [J]. REJUVENATION RESEARCH, 2015, 18 (05) : 413 - 421
  • [6] Regulator of G Protein Signaling 6 (RGS6), A Novel Modulator of Doxorubicin-induced Cardiotoxicity and Apoptosis
    Maity, Biswanath
    Yang, Jianqi
    Huang, Jie
    Fisher, Rory A.
    [J]. FASEB JOURNAL, 2012, 26
  • [7] Role of nuclear calcium/calmodulin-dependent protein kinase II delta B in doxorubicin-induced cardiomyopathy
    Bal, Y
    Williams, T
    Dow, J
    Kloner, RA
    Kedes, L
    Poizat, CI
    [J]. CIRCULATION RESEARCH, 2005, 97 (02) : E20 - E21
  • [8] Role of M6a Methylation in Myocardial Ischemia-Reperfusion Injury and Doxorubicin-Induced Cardiotoxicity
    Liu, Yanfang
    Wu, Hui
    Zhou, Gang
    Zhang, Dong
    Yang, Qingzhuo
    Li, Yi
    Yang, Xiaoting
    Sun, Jianfeng
    [J]. CARDIOVASCULAR TOXICOLOGY, 2024, 24 (09) : 918 - 928
  • [9] Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B
    Tian, Wencong
    Yang, Lei
    Liu, Yuansheng
    He, Jianxiang
    Yang, Liang
    Zhang, Qiong
    Liu, Fei
    Li, Jing
    Liu, Jie
    Sumi, Shoichiro
    Shen, Yanna
    Qi, Zhi
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2020, 79
  • [10] Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model
    Desai, Varsha G.
    Herman, Eugene H.
    Moland, Carrie L.
    Branham, William S.
    Lewis, Sherry M.
    Davis, Kelly J.
    George, Nysia I.
    Lee, Taewon
    Kerr, Susan
    Fuscoe, James C.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2013, 266 (01) : 109 - 121
12345